<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Haemoptysis — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Haemoptysis</h1>
        <div class="sub">Coughing up blood: confirm true haemoptysis, identify life‑threatening bleeding, do baseline assessment/tests, and route for urgent imaging / suspected cancer pathway when indicated.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑10</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points</strong>
                <ul>
                  <li>First decide if this is <strong>true haemoptysis</strong> (lower respiratory tract) vs <strong>pseudohaemoptysis</strong> (epistaxis/post‑nasal bleed) vs <strong>haematemesis</strong>.</li>
                  <li>Identify <strong>life‑threatening haemoptysis</strong> (airway compromise, hypoxia, haemodynamic instability, rapid ongoing bleeding) → <strong>999 / ED</strong>.</li>
                  <li>If stable, the most useful initial test is usually a <strong>CXR</strong>. NICE NG12 includes haemoptysis as a red‑flag symptom for lung cancer assessment/referral pathways.</li>
                  <li>Scottish Right Decisions (NHS Highland) pathway emphasises <strong>urgent CXR</strong> for unexplained haemoptysis and specifies baseline bloods (FBC/U&amp;E/LFT/calcium) to be available for timed lung‑cancer referral acceptance.</li>
                </ul>
              </div>

              <div class="callout warn">
                <strong>Local-process sensitivity</strong>
                <ul>
                  <li>Exact routing differs: direct access CXR vs radiology request, and what is required to trigger/accept a <strong>suspected lung cancer</strong> pathway referral.</li>
                  <li>This page provides a safe <strong>decision structure</strong> + a <strong>local agreement</strong> checklist (so it can be rapidly localised for D&amp;G).</li>
                </ul>
              </div>

              <h4>Comparator sources used for the draft</h4>
              <ul>
                <li>NICE NG12 (Suspected cancer: recognition and referral): lung cancer section (urgent CXR; suspected cancer pathway referral for unexplained haemoptysis age ≥40).</li>
                <li>Right Decisions (NHS Highland): Urgent suspected lung cancer quick reference (urgent CXR for unexplained haemoptysis; baseline blood tests; referral triggers incl persistent haemoptysis in smokers/ex‑smokers &gt;40 even with normal CXR).</li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">
            <div id="draftText" class="section">
              <h3>Haemoptysis (coughing up blood) — adults (primary care)</h3>

              <h4>Definition / scope</h4>
              <ul>
                <li><strong>Haemoptysis</strong> = blood expectorated from the <strong>lower respiratory tract</strong>.</li>
                <li>Applies to adults. Separate pathways needed for children, pregnancy, and significant immunocompromise (lower threshold for same‑day assessment).</li>
              </ul>

              <h4>Immediate red flags (999 / ED now)</h4>
              <ul>
                <li><strong>Airway compromise</strong>, stridor, inability to clear secretions, or rapidly increasing bleeding.</li>
                <li><strong>Respiratory compromise</strong>: severe breathlessness, cyanosis, very low SpO2 on air, exhaustion.</li>
                <li><strong>Haemodynamic instability</strong>: syncope, hypotension, tachycardia, shock, ongoing large‑volume bleeding.</li>
                <li><strong>High-risk context</strong>: known lung cancer, significant underlying lung disease with deterioration, recent major haemoptysis, or on anticoagulants with significant bleeding.</li>
                <li><strong>PE concern with instability</strong> (pleuritic chest pain + breathlessness + haemoptysis + collapse).</li>
              </ul>

              <h4>Step 1 — confirm the source</h4>
              <ul>
                <li><strong>Rule out pseudohaemoptysis:</strong> recent epistaxis, blood in mouth on waking, blood only when blowing nose.</li>
                <li><strong>Rule out haematemesis:</strong> nausea/retching, coffee‑ground material, melaena, known GI bleed risk.</li>
                <li>If unclear and the patient is unwell → treat as high risk and arrange urgent assessment.</li>
              </ul>

              <h4>Step 2 — baseline assessment (stable patient)</h4>
              <ul>
                <li><strong>History:</strong>
                  <ul>
                    <li>Amount/character (streaks vs teaspoons vs clots), frequency, duration, triggers.</li>
                    <li>Associated: fever, pleuritic pain, breathlessness, weight loss, night sweats, hoarseness, chest pain.</li>
                    <li>Infection/TB risk: exposure, travel, immunosuppression.</li>
                    <li>VTE risk: recent surgery/immobility, previous VTE, malignancy, oestrogen therapy.</li>
                    <li>Smoking history; occupational exposure (e.g. asbestos).</li>
                    <li>Medication: anticoagulants/antiplatelets; recent dose changes.</li>
                  </ul>
                </li>
                <li><strong>Observations:</strong> HR, BP, RR, Temp, <strong>SpO2 on air</strong>, mental state.</li>
                <li><strong>Examination:</strong> ENT/oral cavity, chest exam, signs of consolidation/effusion, calf swelling/tenderness, lymphadenopathy.</li>
              </ul>

              <h4>Step 3 — investigations in primary care</h4>
              <ul>
                <li><strong>CXR</strong>: arrange urgently if <strong>unexplained haemoptysis</strong>, recurrent haemoptysis, or cancer risk features.</li>
                <li><strong>Bloods (suggested baseline):</strong> FBC, U&amp;E, LFT, calcium; consider clotting (especially if anticoagulants/bleeding tendency) and CRP if infection suspected.</li>
                <li><strong>Sputum</strong> (if productive): consider culture; consider TB testing if risk features (local process).</li>
              </ul>

              <h4>Likely causes (common patterns)</h4>
              <ul>
                <li><strong>Infection</strong> (acute bronchitis/pneumonia): fever, purulent sputum, pleuritic pain, focal chest signs.</li>
                <li><strong>Malignancy</strong>: persistent/recurrent haemoptysis, weight loss, smoker/ex‑smoker, abnormal CXR.</li>
                <li><strong>Pulmonary embolism</strong>: pleuritic chest pain + breathlessness ± haemoptysis (consider risk factors; follow PE pathway).</li>
                <li><strong>Bronchiectasis/COPD</strong>: chronic sputum, recurrent infections; exacerbations can bleed.</li>
                <li><strong>Upper airway bleed</strong> (pseudohaemoptysis): epistaxis/post‑nasal bleed.</li>
              </ul>

              <h4>Who to refer / where to send</h4>
              <ul>
                <li><strong>Suspected lung cancer pathway referral</strong> (urgent) if:
                  <ul>
                    <li><strong>Unexplained haemoptysis age ≥40</strong> (NICE NG12), or</li>
                    <li><strong>CXR suspicious</strong> (mass/effusion/slowly resolving consolidation), or</li>
                    <li><strong>Persistent symptoms &gt;6 weeks</strong> despite normal CXR (Right Decisions model; local process may vary), especially in smokers/ex‑smokers.</li>
                  </ul>
                </li>
                <li><strong>Same-day hospital assessment</strong> for: ongoing bleeding, physiological compromise, PE concern needing urgent workup, or diagnostic uncertainty in a sick patient.</li>
                <li><strong>Routine respiratory referral</strong> may be appropriate for recurrent small-volume haemoptysis with benign/known cause once cancer/serious causes excluded (local process).</li>
              </ul>

              <h4>Safety-netting (stable, community-managed)</h4>
              <ul>
                <li>Call 999 / attend ED if: bleeding increases, new/worsening breathlessness, chest pain, dizziness/syncope, or SpO2 drops.</li>
                <li>If treated as infection: review if not improving within 48–72 hours, or sooner if worsening.</li>
                <li>Ensure follow-up plan for results (CXR and bloods) and clear escalation advice.</li>
              </ul>

              <h4>Local agreement needed (D&amp;G)</h4>
              <ul>
                <li><label><input type="checkbox" /> What is the local route for <strong>urgent CXR</strong> for haemoptysis (direct access / radiology request / acute assessment)?</label></li>
                <li><label><input type="checkbox" /> For <strong>suspected lung cancer pathway</strong> referral, what are the <strong>acceptance requirements</strong> (CXR mandatory? baseline bloods required: FBC/U&amp;E/LFT/calcium?)</label></li>
                <li><label><input type="checkbox" /> If CXR is normal but haemoptysis persists: local expectation for <strong>CT chest</strong> / respiratory clinic vs 2WW?</label></li>
                <li><label><input type="checkbox" /> TB testing route (who orders? which tests?) for patients with haemoptysis + TB risk factors.</label></li>
              </ul>

              <div class="callout warn">
                <strong>Reminder</strong>
                <div class="small">If there is any physiological compromise or ongoing bleeding, this is not a “routine referral” scenario — send same day.</div>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ul>
                <li>NICE. <em>Suspected cancer: recognition and referral (NG12)</em>. Recommendations organised by site of cancer (lung and pleural cancers). Updated/amended (see NICE page). Accessed 2026‑02‑10. https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer</li>
                <li>Right Decisions (NHS Highland). <em>Urgent suspected Lung Cancer (Guidelines)</em>. Accessed 2026‑02‑10. https://www.rightdecisions.scot.nhs.uk/tam-treatments-and-medicines-nhs-highland/adult-therapeutic-guidelines/respiratory/urgent-suspected-lung-cancer-guidelines/</li>
              </ul>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
